CERUS CORP
CERS · Surgical and Medical Instruments and Apparatus
Latest available SEC filing: 10-Q ·
Latest disclosures
-
Latest financial period: Q3 2026
Financial facts · Filed
-
Form 10-Q
SEC filing · Filed
-
Jensen Chrystal: Form 4
Insider disclosure · Filed · Report period 17 Aug 2026
-
Form 4
SEC filing · Filed
-
Form SCHEDULE 13G/A
SEC filing · Filed
-
Form SCHEDULE 13G/A
SEC filing · Filed
-
Form SCHEDULE 13G/A
SEC filing · Filed
-
Form 10-Q
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
- CERS · 157085101 - Common Stock, par value $0.001 per share
Company details and SEC sources
CIK 0001020214 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- CERS on Nasdaq
- SEC industry group
- Surgical and Medical Instruments and Apparatus (Industrial Applications and Services)
- Business address
- 1220 Concord Avenue, Suite 600, Concord, CA, 94520
- Incorporated in
- DE
- Fiscal year end
- 31 December
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields